Simple charge variant profile comparison of an innovator monoclonal antibody and a biosimilar candidate
Applications | 2018 | Thermo Fisher ScientificInstrumentation
Charge heterogeneity analysis of monoclonal antibodies is essential for ensuring product quality, safety and efficacy. Regulatory approval of biosimilars requires robust comparability studies to demonstrate similarity in charge variant profiles between innovator and biosimilar candidates. A reliable, reproducible separation method simplifies quality control and reduces method development time.
The primary objective is to showcase a straightforward cation-exchange chromatography (CEX) workflow using a linear pH gradient to profile charge variants of an innovator cetuximab mAb and a biosimilar candidate. The study evaluates method reproducibility, resolution, ease of optimization and suitability for comparability assessment.
A pH gradient from 5.6 to 10.2 was generated using Thermo Scientific CX-1 buffer system and applied on a MAbPac SCX-10 (4 × 250 mm, 10 µm) column. Key components:
The optimized shallow pH gradient (Gradient B) resolved ten distinct charge variant peaks for both innovator and biosimilar samples. Compared to the full pH range gradient, the shallow gradient increased resolution of acidic and basic species without extending run time. Retention time precision across six injections showed an average RSD of 0.14 %, ensuring reliable peak identification. Carboxypeptidase B treatment selectively removed peaks corresponding to one or two C-terminal lysine residues, confirming their assignment. Comparison of the two mAbs revealed minor differences in variant distribution, notably in early acidic and basic peaks, illustrating the method’s utility for comparability studies.
This pH-based CEX method offers:
Advancements may include coupling with mass spectrometry for direct variant identification, automation of gradient optimization, and integration with data analytics platforms for real-time comparability assessment. Expanding this platform to other protein therapeutics can streamline quality control workflows.
The combination of Thermo Scientific CX-1 pH gradient buffers, MAbPac SCX-10 column and Vanquish Flex UHPLC provides a simple, reproducible and high-resolution approach for charge variant analysis. This workflow supports efficient comparability studies between innovator mAbs and biosimilar candidates, meeting regulatory and quality control requirements.
HPLC
IndustriesPharma & Biopharma
ManufacturerThermo Fisher Scientific
Summary
Significance of the Topic
Charge heterogeneity analysis of monoclonal antibodies is essential for ensuring product quality, safety and efficacy. Regulatory approval of biosimilars requires robust comparability studies to demonstrate similarity in charge variant profiles between innovator and biosimilar candidates. A reliable, reproducible separation method simplifies quality control and reduces method development time.
Objectives and Overview of the Article
The primary objective is to showcase a straightforward cation-exchange chromatography (CEX) workflow using a linear pH gradient to profile charge variants of an innovator cetuximab mAb and a biosimilar candidate. The study evaluates method reproducibility, resolution, ease of optimization and suitability for comparability assessment.
Methodology and Instrumentation
A pH gradient from 5.6 to 10.2 was generated using Thermo Scientific CX-1 buffer system and applied on a MAbPac SCX-10 (4 × 250 mm, 10 µm) column. Key components:
- Vanquish Flex Quaternary UHPLC system with Quaternary Pump F, Column Compartment H, Split Sampler FT and Diode Array Detector HT (280 nm)
- Thermo Scientific CX-1 pH Gradient Buffers A (pH 5.6) and B (pH 10.2), diluted 1:10
- Mobile phase flow rate of 1.0 mL/min at 30 °C column temperature
- Sample preparation at 5 mg/mL, with optional carboxypeptidase B digestion for C-terminal lysine variant confirmation
Main Results and Discussion
The optimized shallow pH gradient (Gradient B) resolved ten distinct charge variant peaks for both innovator and biosimilar samples. Compared to the full pH range gradient, the shallow gradient increased resolution of acidic and basic species without extending run time. Retention time precision across six injections showed an average RSD of 0.14 %, ensuring reliable peak identification. Carboxypeptidase B treatment selectively removed peaks corresponding to one or two C-terminal lysine residues, confirming their assignment. Comparison of the two mAbs revealed minor differences in variant distribution, notably in early acidic and basic peaks, illustrating the method’s utility for comparability studies.
Benefits and Practical Applications
This pH-based CEX method offers:
- Rapid and robust charge variant profiling in a single run
- Elimination of complex mobile phase formulation and system corrosion risk
- High retention time precision and reproducible gradient preparation
- Ease of method optimization and broad applicability across diverse mAbs
Future Trends and Applications
Advancements may include coupling with mass spectrometry for direct variant identification, automation of gradient optimization, and integration with data analytics platforms for real-time comparability assessment. Expanding this platform to other protein therapeutics can streamline quality control workflows.
Conclusion
The combination of Thermo Scientific CX-1 pH gradient buffers, MAbPac SCX-10 column and Vanquish Flex UHPLC provides a simple, reproducible and high-resolution approach for charge variant analysis. This workflow supports efficient comparability studies between innovator mAbs and biosimilar candidates, meeting regulatory and quality control requirements.
References
- Beck A. et al. Characterisation of Therapeutic Antibodies and Related Products. Analytical Chemistry 2013, 85:715–736.
- Zhang X. et al. Effects of Arginine and Lysine on Monoclonal Antibody C-terminal Lysine Variation. Biotechnol. Prog. 2015, 99:6643–6652.
- Zhang T. et al. Isolation and Characterization of Antibody Charge Variants using Cation Exchange Displacement LC. J. Chromatogr. A 2011, 1218:5079–5086.
- Teshima G. et al. Separation of Oxidized Monoclonal Antibody Variants by Anion Exchange. J. Chromatogr. A 2011, 1218:2091–2097.
- Fekete S. et al. Ion-Exchange Chromatography for Biopharmaceuticals. J. Pharm. Biomed. Anal. 2015, 113:43–55.
- Rea J.C. et al. Validation of a pH Gradient-Based IEX Method for mAb Charge Variants. J. Pharm. Biomed. Anal. 2011, 54:317–323.
- Thermo Scientific Application Note 21788. Evaluation and Application of Salt and pH-Based IEX Gradients for mAb Analysis. 2018.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Evaluation and application of salt- and pH-based ion-exchange chromatography gradients for analysis of therapeutic monoclonal antibodies
2018|Thermo Fisher Scientific|Applications
APPLICATION NOTE 21778 Evaluation and application of salt- and pH-based ion-exchange chromatography gradients for analysis of therapeutic monoclonal antibodies Authors Amy Farrell, Craig Jakes, and Jonathan Bones Characterization and Comparability Laboratory, NIBRT – The National Institute for Bioprocessing Research and…
Key words
absorbance, absorbancecharge, chargevariant, variantmau, maubuffers, buffersmab, mabgradient, gradientvariants, variantsmabs, mabstherapeutic, therapeuticiex, iexsalt, saltmin, mintime, timephosphate
Using the NISTmAb reference standard to demonstrate a simple approach to charge variant analysis
2017|Thermo Fisher Scientific|Applications
APPLICATION NOTE 21684 K KK Using the NISTmAb reference standard to demonstrate a simple approach to charge variant analysis Authors Silvia Millán, Amy Farrell, and Jonathan Bones Characterisation and Comparability Laboratory, NIBRT – The National Institute for Bioprocessing Research and…
Key words
nistmab, nistmabvariants, variantscharge, chargevanquish, vanquishvariant, variantflex, flexpropac, propacuhplc, uhplccpb, cpbreference, referenceemerging, emergingmabs, mabsbuffers, buffersquaternary, quaternarycharacterization
High-Resolution Charge Variant Analysis for Top-Selling Monoclonal Antibody Therapeutics Using a Linear pH Gradient Separation Platform
2016|Thermo Fisher Scientific|Applications
Shanhua Lin and Chris Pohl, Thermo Fisher Scientific, Sunnyvale, CA, USA Key Words Rituxan, rituximab, Herceptin, trastuzumab, Humira, adalimumab, Avastin, bevacizumab, CX-1 pH Gradient Buffer Kit, MAbPac SCX-10, mAb charge variant analysis Goal To develop a high-resolution charge variant analysis…
Key words
absorbance, absorbancemau, mauretention, retentionmin, minsalt, salthalf, halfgradient, gradienttime, timevariant, variantfull, fullvariants, variantscharge, chargeavastin, avastinrituxan, rituxanmethod
Chromatographic Workflows for Biopharmaceutical Characterization
2017|Thermo Fisher Scientific|Presentations
Chromatographic Workflows for Biopharmaceutical Characterization Dr. Ken Cook European Bioseparation Sales Support Expert Thermo Fisher Scientific, Hemel Hempstead/Germany The world leader in serving science Fulfilling the Needs of Biotherapeutic Characterization Charge variant screening Peptide mapping Released glycan analysis Aggregate screening…
Key words
cva, cvamabpac, mabpacthermo, thermovariant, variantscientific, scientificpeptide, peptidemab, mabcharge, chargemapping, mappingexactive, exactivegradient, gradientbiopharma, biopharmavariants, variantsexchange, exchangeanalysis